Personal stuff. Feel free to skip.
Judy and I always look forward to attending Bouchercon. It's the big event of the year for us, and we've been going whenever possible since 1980. We've missed the overseas conventions and the one in New York in 1983, the year we moved here to Alvin and were still recovering from that move and from Hurricane Alicia, which arrived here the same week we did. We also missed the one in Alaska because that one came the year we found out that Judy had non-Hodgkin's lymphoma and because she was undergoing some serious chemo.
Judy's been in treatment ever since, and while she's been in remission a couple of times, it hasn't lasted. Some of you might recall that she was in remission in the early part of this year, but in August we found out that the disease was back. The doctor recommended the full chemo routine again, and this time it's two days in a row. The first day is a long one, seven or eight hours of infusion of two drugs, Rituxan and Bendamustine. The second of the two was approved by the FDA the year after Judy's first treatments, so it's a fairly new one (in the U. S., anyway; it's been used in Germany for a long time). The second day is a shorter, with only Bendamustine being infused.
Judy's had two treatments so far. We think it's working, but she hasn't been tested yet. We'll find out more later. And while she's feeling pretty good except for the week after chemo (she feels rotten then), the third round of treatments is scheduled on October 5-6. Yes, Bouchercon weekend. We couldn't have gone, anyway, because one of the risks of chemo is infection. It wouldn't be wise to fly on a crowed plane and spend four or five days in a convention hotel, and we could take the risk. So we won't be at the Bouchercon. We canceled our hotel reservations, and the Bouchercon folks were very understanding when I asked about a membership refund. Our thanks to all concerned.
We'll be thinking about the convention a lot, of course, and wishing we were there. Maybe we'll make it to Albany in 2013. Here's hoping.